雅培公司宣布其新一代CardioMEMS™远程心衰监测读取器已获得美国食品药品监督管理局批准。该设备旨在优化患者使用体验,同时帮助医护人员更早识别心力衰竭的恶化迹象。
雅培公司宣布其新一代CardioMEMS™远程心衰监测读取器已获得美国食品药品监督管理局批准。该设备旨在优化患者使用体验,同时帮助医护人员更早识别心力衰竭的恶化迹象。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.